BIOMAT Database Logo BIOMAT Database Logo

Nifedipine treatment for Raynaud's phenomenon. 1984

A Kahan, and B Amor, and C J Menkes

UI MeSH Term Description Entries
D009543 Nifedipine A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure. Adalat,BAY-a-1040,Bay-1040,Cordipin,Cordipine,Corinfar,Fenigidin,Korinfar,Nifangin,Nifedipine Monohydrochloride,Nifedipine-GTIS,Procardia,Procardia XL,Vascard,BAY a 1040,BAYa1040,Bay 1040,Bay1040,Monohydrochloride, Nifedipine,Nifedipine GTIS
D011928 Raynaud Disease An idiopathic vascular disorder characterized by bilateral Raynaud phenomenon, the abrupt onset of digital paleness or CYANOSIS in response to cold exposure or stress. Cold Fingers, Hereditary,Raynaud Phenomenon,Raynaud's Disease,Raynauds Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

A Kahan, and B Amor, and C J Menkes
Nifedipine for Raynaud's phenomenon.
January 1983, Lancet (London, England),
A Kahan, and B Amor, and C J Menkes
Raynaud's phenomenon and nifedipine.
July 1989, The Journal of rheumatology,
A Kahan, and B Amor, and C J Menkes
Nifedipine treatment of Raynaud's phenomenon secondary to chemotherapy.
January 1988, Dermatologica,
A Kahan, and B Amor, and C J Menkes
Nifedipine treatment of Raynaud's phenomenon in a paediatric age.
January 1985, International journal of clinical pharmacology research,
A Kahan, and B Amor, and C J Menkes
Slow release nifedipine in the treatment of Raynaud's phenomenon.
January 1987, International angiology : a journal of the International Union of Angiology,
A Kahan, and B Amor, and C J Menkes
Nifedipine as a therapeutic modality for Raynaud's phenomenon.
October 1983, Arthritis and rheumatism,
A Kahan, and B Amor, and C J Menkes
Controlled trial of nifedipine in the treatment of Raynaud's phenomenon.
December 1982, Lancet (London, England),
A Kahan, and B Amor, and C J Menkes
Nifedipine and distal gangrene in Raynaud's phenomenon.
April 1986, The Journal of rheumatology,
A Kahan, and B Amor, and C J Menkes
Ketanserin versus nifedipine in secondary Raynaud's phenomenon.
January 1987, VASA. Zeitschrift fur Gefasskrankheiten,
A Kahan, and B Amor, and C J Menkes
Nifedipine in the treatment of Raynaud's phenomenon. Evidence for inhibition of platelet activation.
April 1985, The American journal of medicine,
Copied contents to your clipboard!